Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 5

1.

Durability and outcome of initial antiretroviral treatments received during 2000--2005 by patients in the Swiss HIV Cohort Study.

Vo TT, Ledergerber B, Keiser O, Hirschel B, Furrer H, Battegay M, Cavassini M, Bernasconi E, Vernazza P, Weber R; Swiss HIV Cohort Study..

J Infect Dis. 2008 Jun 15;197(12):1685-94. doi: 10.1086/588141.

PMID:
18513155
2.

[Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].

Panel de expertos de Gesida y Plan Nacional sobre el Sida..

Enferm Infecc Microbiol Clin. 2009 Apr;27(4):222-35. doi: 10.1016/j.eimc.2008.11.002. Spanish. Erratum in: Enferm Infecc Microbiol Clin. 2009 Oct;27(8):491.

PMID:
19246124
3.

Improvements in antiretroviral therapy outcomes over calendar time.

Boyd MA.

Curr Opin HIV AIDS. 2009 May;4(3):194-9. doi: 10.1097/COH.0b013e328329fc8d. Review.

PMID:
19532050
4.

Initiating therapy: when to start, what to use.

Hirsch MS.

J Infect Dis. 2008 May 15;197 Suppl 3:S252-60. doi: 10.1086/533416. Review.

PMID:
18447611
5.

Antiretroviral therapy: when and what to start-- an American perspective.

Wilkin TJ, Gulick RM.

Curr HIV/AIDS Rep. 2004 Jun;1(2):59-67. Review.

PMID:
16091224

Supplemental Content

Support Center